After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Arcus Biosciences Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Arcus Biosciences Inc is $840.38M. A total of 1.68 million shares were traded on the day, compared to an average of 1.03M shares.
In the most recent transaction, KANEKO YASUNORI bought 20,000 shares of RCUS for 10.06 per share on Feb 27 ’25. After the transaction, the Director now owns 28,400 company shares. In a previous transaction on Feb 27 ’25, ROSEN TERRY J bought 19,800 shares at 10.18 per share. RCUS shares that Chief Executive Officer owns now total 2,554,160.
Among the insiders who bought shares, GILEAD SCIENCES, INC. acquired of 1,363,636 shares on Feb 18 ’25 at a per-share price of $11.00. This resulted in the 10% Owner holding 31,424,760 shares of RCUS after the transaction. In another insider transaction, Goeltz II Robert C. sold 3,594 shares at $15.00 per share on Dec 31 ’24. Company shares held by the Chief Financial Officer now total 60,138.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RCUS has a high of $18.98 and a low of $6.50.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RCUS’s latest balance sheet shows that the firm has $499.00M in Cash & Short Term Investments as of fiscal 2021. There were $116.89M in debt and $166.00M in liabilities at the time. Its Book Value Per Share was $5.26, while its Total Shareholder’s Equity was $842.00M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RCUS is Buy with a score of 4.83.
